Search

everythinglearnresearchcommunity

for

Search:↓

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

Baricitinib is effective and safe for treating severe alopecia areata.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Stem cells are crucial for skin repair and new treatments for chronic wounds.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Once-daily 5% minoxidil foam increases hair regrowth and density in women with hair loss, but not as effectively as twice-daily 2% minoxidil solution, though it's safer and more convenient.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

New regenerative therapies show promise for treating hair loss.

Applying valproic acid on the scalp increased hair growth in men with hair loss.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

The best starting dose for a new finasteride injection is 16.80 mg.

A new model can predict drug-disease links well, helping drug research.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.